Oncolytics Biotech Inc.

US$0.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ONCYHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (14.64%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.24
PE TTM —
TSR TTM (63.08%)
Mkt cap US$56.03M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.418
(4.85%)
(64.25%)
Buy 8|12|4|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
14.28%
16.77%
24.36%
25.74%
Revenue$M
4.094
3.980
3.973
4.088
20.76%
13.57%
7.51%
5.15%
Peers (US$56.03M)
Cap (US$)
PE
56.15M
—
Capital
TTM
5Y
10Y
Leveragex
1.367
0.439
0.382
EBIT/Intx
7.061
0.069
0.080
Own earn%
(29.74)
89.18
103.54
Sh yield%
49.87
49.42
47.03
Owners
Insiders/Inst%
8.82
66.52
Short interest%
2.56
SBC / revenue%
1.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
24–29
$1 testx
−0.4
Incr. ROIC%
1